FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985161719> ?p ?o ?g. }

• W1985161719 endingPage "468" @default.
• W1985161719 startingPage "465" @default.
• W1985161719 abstract "In patients with hematologic malignancies, chemotherapy can further suppress bone marrow production. Whereas measures to correct anemia can improve patients' function and quality of life, the intervention threshold and the methods of correcting anemia in patients with malignant lymphoma are not clear. This study evaluates the frequency of anemia and the interventions used to correct anemia before and during chemotherapy for patients with Hodgkin and non-Hodgkin lymphomas.A retrospective electronic chart review was conducted of 312 patients who received cytotoxic chemotherapy for malignant lymphoma at 4 British Columbia Cancer Agency centers from June 1, 2004 to May 1, 2006. The chemotherapy regimens delivered were: doxorubicin, cyclophosphamide, vincristine, and prednisone (CHOP) in 24 patients, CHOP + Rituximab (CHOP-R) in 215 patients, and Adriamycin, bleomycin, vinblastine, dacarbazine in 73 patients. Initial hemoglobin (Hgb) and dates of lowest Hgb in the ranges, 110 to 119, 100 to 109, 90 to 99, 80 to 89, and <80 g/L were recorded. Review of medical records was performed to document the frequency of symptoms that may be related to anemia and the frequency of any discussion or intervention for anemia such as transfusion or erythropoietin (Epo).The median age was 57 years (range, 16-87 years). About 24% of patients had Hodgkin's and 76% had non-Hodgkin's lymphoma. Prior to starting chemotherapy, 34% of subjects had an Hgb <120 g/L and 11% of subjects had an Hgb <100 g/L. In all patients with Hgb <120 g/L prechemotherapy, symptoms of anemia were documented in 57% but intervention to correct anemia occurred in only 4% of patients. During chemotherapy, 42% of subjects had a Hgb <120 g/L and 12% had a Hgb <100 g/L. Discussion and intervention rates increased with declining Hgb, particularly at levels <100 g/L. Among 36 patients with Hgb <100 g/L, symptoms were documented in 31 patients. Transfusion was used in 24 patients and Epo in 2 patients. During chemotherapy, 63% of patients with Hgb <120 g/L were symptomatic, but only 20% received an intervention to correct anemia.Anemia was common prior to and during chemotherapy in patients with malignant lymphoma. The threshold of anemia intervention varied, with transfusion being the predominant method used. The rates of intervention for anemia were low in patients with anemia, despite randomized trials showing that anemia correction can improve fatigue and quality of life." @default.
• W1985161719 created "2016-06-24" @default.
• W1985161719 creator A5006264564 @default.
• W1985161719 creator A5039148548 @default.
• W1985161719 creator A5047600740 @default.
• W1985161719 creator A5079836541 @default.
• W1985161719 creator A5091101559 @default.
• W1985161719 date "2010-10-01" @default.
• W1985161719 modified "2023-10-13" @default.
• W1985161719 title "Population-Based Analysis of the Frequency of Anemia and its Management Before and During Chemotherapy in Patients With Malignant Lymphoma" @default.
• W1985161719 cites W1276432619 @default.
• W1985161719 cites W1547120031 @default.
• W1985161719 cites W1771031878 @default.
• W1985161719 cites W1970997581 @default.
• W1985161719 cites W1976224649 @default.
• W1985161719 cites W2001453738 @default.
• W1985161719 cites W2004513962 @default.
• W1985161719 cites W2010224434 @default.
• W1985161719 cites W2027562550 @default.
• W1985161719 cites W2044412852 @default.
• W1985161719 cites W2063931484 @default.
• W1985161719 cites W2069222290 @default.
• W1985161719 cites W2086574424 @default.
• W1985161719 cites W2091697700 @default.
• W1985161719 cites W2096760803 @default.
• W1985161719 cites W2130028945 @default.
• W1985161719 cites W2139060631 @default.
• W1985161719 cites W2145869599 @default.
• W1985161719 cites W2159280529 @default.
• W1985161719 cites W2159923585 @default.
• W1985161719 cites W2163830215 @default.
• W1985161719 cites W2168236050 @default.
• W1985161719 cites W2170548329 @default.
• W1985161719 cites W2171137595 @default.
• W1985161719 cites W2179208207 @default.
• W1985161719 cites W4296277331 @default.
• W1985161719 cites W4297940827 @default.
• W1985161719 doi "https://doi.org/10.1097/coc.0b013e3181b4b147" @default.
• W1985161719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19935386" @default.
• W1985161719 hasPublicationYear "2010" @default.
• W1985161719 type Work @default.
• W1985161719 sameAs 1985161719 @default.
• W1985161719 citedByCount "10" @default.
• W1985161719 countsByYear W19851617192013 @default.
• W1985161719 countsByYear W19851617192015 @default.
• W1985161719 countsByYear W19851617192017 @default.
• W1985161719 countsByYear W19851617192019 @default.
• W1985161719 countsByYear W19851617192021 @default.
• W1985161719 countsByYear W19851617192022 @default.
• W1985161719 crossrefType "journal-article" @default.
• W1985161719 hasAuthorship W1985161719A5006264564 @default.
• W1985161719 hasAuthorship W1985161719A5039148548 @default.
• W1985161719 hasAuthorship W1985161719A5047600740 @default.
• W1985161719 hasAuthorship W1985161719A5079836541 @default.
• W1985161719 hasAuthorship W1985161719A5091101559 @default.
• W1985161719 hasConcept C126322002 @default.
• W1985161719 hasConcept C141071460 @default.
• W1985161719 hasConcept C2776305933 @default.
• W1985161719 hasConcept C2776694085 @default.
• W1985161719 hasConcept C2776755627 @default.
• W1985161719 hasConcept C2777132456 @default.
• W1985161719 hasConcept C2778248108 @default.
• W1985161719 hasConcept C2779338263 @default.
• W1985161719 hasConcept C2779429289 @default.
• W1985161719 hasConcept C2779725641 @default.
• W1985161719 hasConcept C2780653079 @default.
• W1985161719 hasConcept C71924100 @default.
• W1985161719 hasConcept C90924648 @default.
• W1985161719 hasConceptScore W1985161719C126322002 @default.
• W1985161719 hasConceptScore W1985161719C141071460 @default.
• W1985161719 hasConceptScore W1985161719C2776305933 @default.
• W1985161719 hasConceptScore W1985161719C2776694085 @default.
• W1985161719 hasConceptScore W1985161719C2776755627 @default.
• W1985161719 hasConceptScore W1985161719C2777132456 @default.
• W1985161719 hasConceptScore W1985161719C2778248108 @default.
• W1985161719 hasConceptScore W1985161719C2779338263 @default.
• W1985161719 hasConceptScore W1985161719C2779429289 @default.
• W1985161719 hasConceptScore W1985161719C2779725641 @default.
• W1985161719 hasConceptScore W1985161719C2780653079 @default.
• W1985161719 hasConceptScore W1985161719C71924100 @default.
• W1985161719 hasConceptScore W1985161719C90924648 @default.
• W1985161719 hasIssue "5" @default.
• W1985161719 hasLocation W19851617191 @default.
• W1985161719 hasLocation W19851617192 @default.
• W1985161719 hasOpenAccess W1985161719 @default.
• W1985161719 hasPrimaryLocation W19851617191 @default.
• W1985161719 hasRelatedWork W1977168953 @default.
• W1985161719 hasRelatedWork W1994837348 @default.
• W1985161719 hasRelatedWork W2068354603 @default.
• W1985161719 hasRelatedWork W2088539798 @default.
• W1985161719 hasRelatedWork W2130595908 @default.
• W1985161719 hasRelatedWork W2162714191 @default.
• W1985161719 hasRelatedWork W2335762340 @default.
• W1985161719 hasRelatedWork W2339248445 @default.
• W1985161719 hasRelatedWork W2887013637 @default.
• W1985161719 hasRelatedWork W2970608623 @default.
• W1985161719 hasVolume "33" @default.
• W1985161719 isParatext "false" @default.

• next